Lyondell Reports Third Quarter 2001 Results; Business and Capital Structures Further Optimized in Weak Business Climate
    Highlights
    - Refining posts record EBITDA of $116 million.
    - LCR and Equistar refinanced, extending debt maturities and enhancing
      liquidity.
    - Lyondell exits ADI business, takes a $78 million charge.

HOUSTON, Oct. 25 /PRNewswire/ -- Lyondell Chemical Company (NYSE: LYO) had a net loss excluding unusual charges for the third quarter of 2001 of $16 million, or $0.13 per share.

Lyondell's reported third quarter 2001 loss was $67 million, or $0.57 per share, including unusual charges related to the shutdown of the ADI (aliphatic diisocyanates) business at Lake Charles, LA.

"Business conditions remained very difficult during the third quarter, as we had anticipated," said Dan F. Smith, President and CEO. "While our third quarter results benefited from record performance in refining, as well as continued declines in natural gas and energy costs, these improvements were more than offset by lower margins in many of Lyondell's businesses, primarily petrochemicals and MTBE.

"Nevertheless, we made progress during the quarter on several important fronts. We generated significant cash flow from working capital, helping increase Lyondell's end-of-quarter cash balance by $117 million from the second quarter of 2001, and Equistar's by $56 million. We completed debt refinancings for both LCR and Equistar. Equistar's debt maturities were extended over a period more consistent with our expectations for improved business conditions. Further, the financing provided Equistar with significant liquidity. We also announced our decision to exit the ADI business because we did not see its potential for delivering the returns that would justify our continued participation."

                        Lyondell Earnings Summary (A)

    Millions of dollars        3Q2001   2Q2001   3Q2000   1st Nine   1st Nine
     except per share amounts                               Months     Months
                                                             2001       2000
    Net Income (Loss) Before
     Unusual Items (B)(C)         $(16)      $4      $62      $(40)      $115
    Earnings (Loss) per Share
     Before Unusual
     Items (B)(C)               $(0.13)    $.04    $0.52    $(0.33)     $0.97
    Net Income (Loss) As
     Reported                     $(67)      $4     $133      $(97)      $485
    Earnings (Loss) per Share
     As Reported                $(0.57)    $.04    $1.13    $(0.82)     $4.12
    EBITDA (Lyondell and
     proportionate share of
     ventures) Before Unusual
     Items (B)(C)                 $193     $235     $324      $602       $928

    (A)  See Consolidated Income Statements.
    (B)  The third quarter 2001 excludes the unusual charge related to the ADI
         shutdown of $51 million after tax, or $0.44 per share.  The first
         nine months 2001 exclude the ADI shutdown charge as well as an
         after-tax charge of $6 million, or $0.05 per share, consisting of
         Lyondell's share of Equistar's facility shutdown costs.
    (C)  The third quarter 2000 excludes a favorable after-tax adjustment of
         the gain on asset sale of $31 million, or $0.26 per share, and a
         favorable effect from a tax rate revision of $40 million, or
         $0.35 per share.  The first nine months 2000 exclude the after-tax
         gain on asset sale of $400 million, or $3.40 per share, and the
         after-tax extraordinary loss of $30 million, or $0.25 per share,
         related to early debt reduction.


The third quarter 2001 net loss before unusual charges of $16 million, or $0.13 per share, compares to net income of $4 million, or $0.04 per share, in the second quarter of 2001. Third quarter 2001 EBITDA (earnings before interest, taxes, depreciation and amortization) before unusual charges for Lyondell and its proportionate share of the joint ventures was $193 million, compared to $235 million in the second quarter 2001.

The third quarter 2001 net loss before unusual charges compares to net income before unusual items of $62 million, or $0.52 per share, in the third quarter of 2000. The third quarter of 2000 was characterized by stronger margins in petrochemicals and the extension of the MTBE seasonal margin peak into the third quarter.

INTERMEDIATE CHEMICALS AND DERIVATIVES (IC&D)

The IC&D segment includes propylene oxide (PO) and derivatives, styrene monomer and MTBE. EBITDA for the third quarter of 2001 was $110 million excluding unusual charges, compared to $128 million in the second quarter of 2001 and $179 million in the third quarter of 2000.

The decrease in EBITDA from the second quarter of 2001 is due in large part to the seasonal downturn in MTBE margins, consistent with the end of the summer driving season. The decrease was somewhat offset by higher margins in our PO and derivatives business due to lower propylene, natural gas and energy costs. Volumes were relatively unchanged in PO and derivatives versus the second quarter of 2001.

EQUISTAR CHEMICALS, LP

Equistar's EBITDA for the third quarter of 2001 was $46 million, excluding a $3 million extraordinary charge associated with the write-off of financing costs related to the credit facility refinanced in August 2001. This compares to $96 million in the second quarter of 2001 and $186 million in the third quarter of 2000.

The Petrochemicals segment reported EBITDA of $79 million in the third quarter of 2001, compared to $131 million in the second quarter. The decrease was due primarily to falling ethylene and co-product prices, which were only partially offset by falling feedstock, natural gas and energy costs. Ethylene volumes were largely unchanged versus the second quarter of 2001.

The Polymers segment reported negative EBITDA of $10 million in the third quarter of 2001, compared to negative $9 million in the second quarter of 2001. Polymers prices fell more than feedstock costs. The resulting margin erosion during the quarter was largely offset by a 12 percent increase in polymers sales volumes.

LYONDELL-CITGO REFINING LP (LCR)

LCR had record EBITDA of $116 million in the third quarter of 2001, compared to $108 million in the second quarter 2001, and $110 million in the third quarter of 2000, the previous quarterly record.

Compared to its performance in the second quarter of 2001, LCR's third quarter 2001 performance is the result of record operational performance in July and August, lower natural gas and energy costs, and higher contract margins. These benefits were partially offset by an unplanned outage in September of the fluid catalytic cracking unit (FCCU) that negatively impacted third quarter results by approximately $10 million, as well as lower spot crude margins compared to the second quarter 2001.

Refinery processing rates were 270,000 barrels of crude oil per day during the third quarter of 2001, compared to 256,000 barrels per day in the second quarter of 2001. CSA (crude supply agreement) crude comprised 253,000 barrels per day of the third quarter 2001 total.

In the fourth quarter of 2001, LCR will complete major turnarounds in a coker unit, the FCCU and a crude unit. These planned outages are expected to reduce crude processing rates in the fourth quarter to approximately 215,000 barrels per day, essentially all of which is expected to be CSA volume.

OUTLOOK

"For the fourth quarter we expect continued trough conditions in the global chemical markets, which Equistar serves," Smith said. "While we see no change in most of our IC&D businesses, we do expect further seasonal declines in MTBE. LCR will experience a significant decline in production as a result of the major planned maintenance work. We expect LCR's EBITDA in the fourth quarter could be reduced by approximately 50 percent from the third quarter 2001.

"As trough conditions continue, we will continue to take the appropriate and necessary steps not only to manage through the current difficult business environment, but also to position Lyondell to take full advantage of improvements in the market when they come.

"We aggressively controlled costs in the third quarter of this year. The cash management and fixed-cost reduction initiatives that we implemented already have generated results. We believe we will continue to make progress on cost reduction through next year."

                                Sales Revenues

    Millions of dollars     3Q2001    2Q2001    3Q2000    1st Nine    1st Nine
                                                           Months      Months
                                                            2001        2000

    Reported sales revenues   $750      $902      $975     $2,509      $3,087
    Total sales revenues
     - all businesses in
     which Lyondell
     participates (A)       $2,980    $3,487    $4,156    $10,052     $11,852
    Lyondell's proportionate
     share of the sales
     revenues of businesses
     in which it
     participates (A)       $1,825    $2,145    $2,505     $6,122      $7,241

    (A)  Includes revenues from sales to affiliates.


Lyondell Chemical Company (www.lyondell.com ), with headquarters in Houston, Texas, is the world's largest producer of propylene oxide (PO); the world's number three supplier of TDI (toluene diisocyanate); a leading producer of propylene glycol; a leading producer of other PO derivatives such as BDO (butanediol) and PGE (propylene glycol ether); and a producer of styrene monomer and MTBE as co-products of PO production. Through its 41% interest in Equistar Chemicals, LP, Lyondell also is one of the largest producers of ethylene, propylene and polyethylene in North America and a leading producer of polypropylene, ethylene oxide, ethylene glycol, high value-added specialty polymers and polymeric powder. Through its 58.75% interest in LYONDELL-CITGO Refining LP, Lyondell is one of the largest refiners in the United States, processing extra heavy Venezuelan crude oil to produce gasoline, low sulfur diesel and jet fuel. Lyondell is the third largest methanol producer in the U.S., through its 75% interest in Lyondell Methanol Company, L.P.

The statements in this release relating to matters that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, future global economic conditions, technological developments, availability of capital markets, industry production capacity and operating rates, the supply/demand balance for Lyondell's and its joint ventures' products, competitive products and pricing pressures, further increases in raw material and/or energy costs, changes in governmental regulations and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to Lyondell's Annual Report on Form 10-K for the year ended December 31, 2000, filed with the Securities and Exchange Commission in March 2001, and Lyondell's Quarterly Report on Form 10-Q for the quarter ended September 30, 2001, which will be filed in November 2001.

                          LYONDELL CHEMICAL COMPANY
           SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)
                            (Millions of dollars)

                              Lyondell Chemical                 Lyondell and
                                  Company                       Proportionate
                                (Excluding    Joint Ventures      Share of
                                  Equity    Equistar LCR   LMC      Equity
                              Investments)(A) 100%   100%  100% Investments(B)

    Three months ended
     September 30, 2001:

      Sales and other
       operating revenues (C)      $750     $1,351   $850   $29      $1,825

      SG&A and R&D                   40         49     16     2          71

      EBITDA before unusual and
       extraordinary charges        110         46    116    (6)        193

      Depreciation and amortization  67(D)      80(F)  26     2         114

      Net interest expense           91(D)      46(F)  10   ---         116

      Capital expenditures           12(E)      32     30   ---          43

      Dividends                      26                                  26

    Three months ended June 30,
     2001:

      Sales and other
       operating revenues (C)      $902     $1,600   $932   $53       2,145

      SG&A and R&D                   49         55     14     2          81

      EBITDA                        128         96    108     6         235

      Depreciation and amortization  67(D)      81     27     2         115

      Net interest expense           94(D)      45     15   ---         121

      Capital expenditures           29(E)      29     18   ---          51

      Dividends                      26                                  26

    Three months ended
     September 30, 2000:

      Sales and other
       operating revenues (C)      $975     $1,955 $1,177   $49      $2,505

      SG&A and R&D                   57         58     18     3          94

      EBITDA                        179        186    110     6         324

      Depreciation and amortization  69(D)      78     28     3         117

      Net interest expense          104(D)      45     16   ---         132

      Capital expenditures           47         33     11   ---          67

      Dividends                      27                                  27

    (A)  Consists of the operations of the Intermediate Chemicals and
         Derivatives business segment.
    (B)  This column reflects a combined total of Lyondell's 100% owned
         operations and its pro rata share of each joint venture's operations
         and is not a presentation in accordance with generally accepted
         accounting principles.  Lyondell currently owns a 41% interest in
         Equistar Chemicals, LP ("Equistar"), a 58.75% interest in
         LYONDELL-CITGO Refining LP ("LCR") and a 75% interest in Lyondell
         Methanol Company, L.P. ("LMC").
    (C)  Includes revenues from sales to affiliates.
    (D)  "Depreciation and amortization" and "net interest expense" both
         include approximately $4 million, $4 million and $3 million of
         non-cash amortization of debt issuance costs in the three-month
         periods ended September 30, 2001, June 30, 2001, and September 30,
         2000, respectively.
    (E)  Excludes contributions to PO-11 joint venture of $44 million in the
         three-month period ended September 30, 2001 and $15 million in the
         three-month period ended June 30, 2001.
    (F)  "Depreciation and amortization" and "net interest expense" both
         include approximately $1 million of non-cash amortization of debt
         issuance costs in the three-month period ended September 30, 2001.


                          LYONDELL CHEMICAL COMPANY
           SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

    INCOME STATEMENTS                For the three months  For the nine months
    (Millions of dollars, except      ended September 30,  ended September 30,
     per share data)                       2001     2000       2001     2000

    Sales and other operating revenues     $750     $975     $2,509   $3,087
    Operating costs and expenses:
      Cost of sales                         633      793      2,149    2,514
      Selling, general and
       administrative expenses               32       51        112      139
      Research and development                8        6         24       27
      Amortization of goodwill and
       other intangibles                     25       28         75       81
      Unusual charges                        78      ---         78      ---
        Operating income (loss)             (26)      97         71      326
    Income (loss) from equity investment
     in Equistar                            (24)      35        (48)     140
    Income from equity investment in LCR     48       42        116       48
    Income (loss) from other equity
     investments                             (7)       6         (7)      11
    Interest expense, net                   (91)    (104)      (277)    (364)
    Other income (expense), net              (4)      14         (2)       8
    Gain on sale of assets                  ---       46        ---      590
      Income (loss) before income taxes
       and extraordinary item              (104)     136       (147)     759
    Provision for (benefit from) income
     taxes                                  (37)       3        (50)     244
      Income (loss) before
       extraordinary item                   (67)     133        (97)     515
    Extraordinary loss, net of
     income taxes                           ---      ---        ---      (30)
    Net income (loss)                      $(67)    $133       $(97)    $485

    Basic earnings per share:
      Income (loss) before
       extraordinary item                 $(0.57)   $1.13     $(0.82)   $4.38
      Net income (loss)                   $(0.57)   $1.13     $(0.82)   $4.13
      Weighted average shares
       outstanding (in thousands)        117,563  117,556    117,563  117,556
    Diluted earnings per share:
      Income (loss) before
       extraordinary item                 $(0.57)   $1.13     $(0.82)   $4.37
      Net income (loss)                   $(0.57)   $1.13     $(0.82)   $4.12
      Weighted average shares
       outstanding (in thousands)        117,563  117,721    117,563  117,808


     INTERMEDIATE CHEMICALS AND
      DERIVATIVES SEGMENT
      SELECTED FINANCIAL AND OPERATING
      INFORMATION
     (Millions of dollars)
     Sales and other operating revenues     $750     $975     $2,509   $3,087
     Operating income (loss)                 (26)      97         71      326
     EBITDA before unusual and
      extraordinary charges                  110      179        335      547

     Sales Volumes (millions)
     PO and derivatives (pounds) (A)         694      720      2,064    2,600
     Co-products:
       Styrene monomer (pounds)              767      882      2,345    2,670
       TBA and derivatives (gallons)         307      299        873      891

    (A)  Includes propylene oxide ("PO"), PO derivatives and isocyanates.  The
         polyols business sold to Bayer on March 31, 2000 is included through
         the date of sale.


                          LYONDELL CHEMICAL COMPANY
                  SELECTED FINANCIAL INFORMATION (UNAUDITED)
                            (Millions of dollars)

                                                       For the nine months
                                                       ended September 30,
    STATEMENTS OF CASH FLOWS                         2001               2000

    Net income (loss)                                $(97)              $485
    Adjustments to reconcile net income (loss)
     to net cash provided by operating activities:
      Gain on sale of assets                          ---               (590)
      Depreciation and amortization                   199                219
      Extraordinary loss                              ---                 30
      Unusual charges                                  78                ---
      Accounts receivable                             127               (134)
      Inventories                                      22                (28)
      Accounts payable                               (101)                44
      Changes in other working capital and
       other, net                                     (42)                11
        Net cash provided by operating activities     186                 37

    Proceeds from sale of assets, net of cash sold    ---              2,445
    Expenditures for property, plant and equipment    (52)               (78)
    Contributions and advances to affiliates (A)     (108)               (28)
    Distributions from affiliates in excess of
     earnings                                          30                ---
        Net cash (used in) provided by investing
         activities                                  (130)             2,339

    Repayments of long-term debt                       (8)            (2,064)
    Dividends paid                                    (79)               (79)
    Other                                              (7)               (18)
        Net cash used in financing activities         (94)            (2,161)

    Effect of exchange rate changes on cash           ---                 (6)

    (Decrease) increase in cash and cash equivalents $(38)              $209

    (A)  Includes contributions to PO-11 joint venture of $74 million and
         $2 million in the nine-months ended September 30, 2001 and
         September 30, 2000, respectively.


                          LYONDELL CHEMICAL COMPANY
                  SELECTED FINANCIAL INFORMATION (UNAUDITED)
                            (Millions of dollars)

                                                  September 30,   December 31,
    BALANCE SHEET                                     2001           2000

    Cash and cash equivalents                         $222           $260
    Accounts receivable, net                           386            508
    Inventories                                        368            392
    Prepaid expenses and other current assets           96             49
    Deferred tax assets                                232            136
      Total current assets                           1,304          1,345
    Property, plant and equipment, net               2,374          2,429
    Investments and long-term receivables:
      Investment in PO joint ventures                  690            621
      Investment in Equistar                           550            599
      Receivable from LCR                              229            229
      Investment in LCR                                 33             20
      Investment in LMC                                 38             49
      Other investments and long-term receivables       85             88
    Goodwill, net                                    1,115          1,152
    Other assets                                       529            515
      Total assets                                  $6,947         $7,047

    Accounts payable                                  $296           $401
    Current maturities of long-term debt                10             10
    Other accrued liabilities                          398            323
      Total current liabilities                        704            734
    Long-term debt, less current maturities          3,836          3,844
    Other liabilities                                  498            441
    Deferred income taxes                              784            702
    Minority interest                                  170            181
    Stockholders' equity (117,562,920 and
     117,560,333 shares outstanding respectively
     at September 30, 2001 and December 31, 2000)      955          1,145
      Total liabilities and stockholders' equity    $6,947         $7,047


    Investment in Equistar, December 31, 2000         $599
    Lyondell's share of Equistar net loss              (48)
    Other                                               (1)
    Investment in Equistar, September 30, 2001        $550

    Investment in LCR, December 31, 2000               $20
    Lyondell's share of LCR net income                 116
    Cash distributions from LCR                       (131)
    Cash contributions to LCR                           28
    Investment in LCR, September 30, 2001              $33

    Investment in LMC, December 31, 2000               $49
    Lyondell's share of LMC net loss                    (7)
    Cash distributions from LMC                        (10)
    Cash contributions to LMC                            6
    Investment in LMC, September 30, 2001              $38


                          LYONDELL CHEMICAL COMPANY
                            EQUISTAR CHEMICALS, LP
           SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

                                    For the three months   For the nine months
     INCOME STATEMENTS                ended September 30,  ended September 30,
     (Millions of dollars)               2001      2000      2001      2000

     Sales and other operating
      revenues (A)                      $1,351    $1,955    $4,724    $5,712
     Operating costs and expenses:
       Cost of sales                     1,328     1,779     4,573     5,111
       Selling, general and
        administrative expenses             40        49       131       142
       Research and development              9         9        29        28
       Amortization of goodwill              8         9        25        25
       Restructuring and unusual charges   ---       ---        22       ---
         Operating income (loss)           (34)      109       (56)      406
     Interest expense, net                 (46)      (45)     (137)     (134)
     Other income (expense), net             1        (1)        7        (1)
     Income (loss) before extraordinary
      loss                                 (79)       63      (186)      271
     Extraordinary loss                     (3)      ---        (3)      ---
     Net income (loss) (B)                $(82)      $63     $(189)     $271

     SELECTED FINANCIAL AND OPERATING
      INFORMATION
     (Millions of dollars)
     Sales and Other Operating
      Revenues (A)
     Petrochemicals segment             $1,181    $1,848    $4,345    $5,334
     Polymers segment                      494       602     1,552     1,813
     Intersegment eliminations            (324)     (495)   (1,173)   (1,435)
       Total                            $1,351    $1,955    $4,724    $5,712
     Other Operating Expenses (C)
     Petrochemicals segment               $---        $2        $7        $6
     Polymers segment                       20        16        57        52
     Unallocated                            37        49       121       137
       Total                               $57       $67      $185      $195
     Operating Income (Loss)
     Petrochemicals segment                $29      $204      $225      $643
     Polymers segment                      (26)      (46)     (138)     (100)
     Unallocated                           (37)      (49)     (143)     (137)
       Total                              $(34)     $109      $(56)     $406
     EBITDA
     Petrochemicals segment                $79      $255      $376      $794
     Polymers segment                      (10)      (31)      (94)      (60)
     Unallocated                           (26)      (38)      (96)      (99)
       Total                               $43      $186      $186      $635

     EBITDA before unusual
      and extraordinary charges            $46      $186      $211      $635

     Sales Volumes (A)
     Selected petrochemical products
      (millions):
       Ethylene, propylene and other
        olefins (pounds)                 4,039     4,512    12,352    14,020
       Aromatics (gallons)                  86       101       274       312
     Polymers products (millions of
      pounds)                            1,565     1,622     4,402     4,763

    (A)  Includes revenues/volumes from sales to affiliates.
    (B)  As a partnership, Equistar is not subject to federal income taxes.
    (C)  Other Operating Expenses include SG&A, R&D and amortization of
         goodwill.

                          LYONDELL CHEMICAL COMPANY
                            EQUISTAR CHEMICALS, LP
                  SELECTED FINANCIAL INFORMATION (UNAUDITED)
                            (Millions of dollars)

                                                   September 30,  December 31,
     BALANCE SHEETS                                    2001           2000

     Cash and cash equivalents                         $113            $18
     Accounts receivable, net                           662            758
     Inventories                                        504            506
     Prepaid expenses and other current assets           33             50
       Total current assets                           1,312          1,332
     Property, plant and equipment, net               3,731          3,819
     Goodwill, net                                    1,061          1,086
     Other assets                                       338            345
       Total assets                                  $6,442         $6,582

     Accounts payable                                  $451           $487
     Current maturities of long-term debt               104             90
     Other accrued liabilities                          146            166
       Total current liabilities                        701            743
     Long-term debt, less current maturities          2,234          2,158
     Other liabilities                                  150            141
     Partners' capital                                3,357          3,540
       Total liabilities and partners' capital       $6,442         $6,582


                                     For the three months  For the nine months
                                      ended September 30,  ended September 30,
     SELECTED CASH FLOW INFORMATION     2001        2000    2001        2000

     Depreciation and amortization       $80         $78    $239        $230
     Cash flow from operations            24          54     119         313
     Capital expenditures                 32          33      85          81


                          LYONDELL CHEMICAL COMPANY
                          LYONDELL-CITGO REFINING LP
           SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

    CONDENSED BALANCE SHEETS                     September 30,    December 31,
    (Millions of dollars)                            2001            2000

    Total current assets                              $292            $310
    Property, plant and equipment, net               1,321           1,319
    Deferred charges and other assets                   64              67
      Total assets                                  $1,677          $1,696

    Notes payable                                     $---            $450
    Other current liabilities                          434             417
    Long-term debt                                     450             ---
    Loans payable to partners                          264             264
    Other liabilities and deferred credits              62              57
    Partners' capital                                  467             508
      Total liabilities and partners' capital       $1,677          $1,696


                                     For the three months  For the nine months
    INCOME STATEMENTS                 ended September 30,  ended September 30,
    (Millions of dollars)               2001     2000        2001      2000

    Sales and other operating
     revenues (A)                       $850    $1,177      $2,692   $2,937
    Operating costs and expenses:
      Cost of sales                      744     1,077       2,419    2,781
      Selling, general and
       administrative expenses            16        18          44       46
        Operating income                  90        82         229      110
    Interest expense, net                (10)      (16)        (41)     (44)
      Income before extraordinary item    80        66         188       66
     Extraordinary loss, net of income
      taxes                               (2)      ---          (2)     ---
     Net income (B)                      $78       $66        $186      $66

    SELECTED CASH FLOW INFORMATION
    (Millions of dollars)
    Depreciation and amortization        $26       $28         $81      $84
    Cash flow from operations            183       103         273      130
    Capital expenditures                  30        11          59       46

    EBITDA before extraordinary item    $116      $110        $310     $194

    SELECTED OPERATING INFORMATION
    Sales Volumes (including
     intersegment sales) (A)
    Refined products (thousand barrels
     per day):
      Gasoline                           103       122         107      117
      Diesel and heating oil              80        81          74       69
      Jet fuel                            24        24          22       17
      Aromatics                            7        13           8       11
      Other refinery products            109       109         106      103
        Total refined products volumes   323       349         317      317

    Refinery Runs
    Crude processing rates (thousand
     barrels per day):
      Crude Supply Agreement - coked     253       244         240      188
      Other heavy crude oil - coked      ---       ---          11       14
      Other crude oil                     16        26          10       34
        Total crude oil                  269       270         261      236

    (A)  Includes revenues/volumes from sales to affiliates.
    (B)  As a partnership, LCR is not subject to federal income taxes.

                    MAKE YOUR OPINION COUNT -  Click Here
               http://tbutton.prnewswire.com/prn/11690X53762615

SOURCE Lyondell Chemical Company
Web site: http: //www.lyondell.com
Photo: NewsCom: http: //www.newscom.com/cgi-bin/prnh/20000921/LYOLOGO AP Archive: http://photoarchive.ap.org PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840
CONTACT: media, Anne M. Knisely, +1-713-309-2643, or investors, Patrick Quarles, +1-713-309-7141, both of Lyondell Chemical Company
CAPTION: LYOLOGO LYONDELL LOGO Lyondell Logo. (PRNewsFoto)[PM] HOUSTON, TX USA 09/21/2000


email Email Page   print Print